Advertisement
Screener

TVARDI THERAPEUTICS, INC. (TVRD) Increase (Decrease) in Other Receivables

2.8 / 5 stars · 68/120 Roast Me

TVARDI THERAPEUTICS, INC. Increase (Decrease) in Other Receivables

TVARDI THERAPEUTICS, INC. (TVRD) reported Increase (Decrease) in Other Receivables of -$579.00 thousand for the 3-month period ending 2025-03-31, per its 10-Q filed 2025-05-13.

Financial Statements › Cash Flow › Operating Activities

us-gaap:IncreaseDecreaseInOtherReceivables · last filed 2025-05-13

  • TVARDI THERAPEUTICS, INC. increase (decrease) in other receivables for the quarter ending 2025-03-31 was -$579.00K.
  • TVARDI THERAPEUTICS, INC. increase (decrease) in other receivables for the quarter ending 2024-12-31 was $655.00K.
  • TVARDI THERAPEUTICS, INC. increase (decrease) in other receivables for the quarter ending 2024-09-30 was $170.00K, a 86.53% decline year-over-year.
  • TVARDI THERAPEUTICS, INC. increase (decrease) in other receivables for the quarter ending 2024-06-30 was $258.00K.
  • TVARDI THERAPEUTICS, INC. increase (decrease) in other receivables for fiscal 2024 was $1.03M, a 1652.54% increase from fiscal 2023.
  • TVARDI THERAPEUTICS, INC. increase (decrease) in other receivables for fiscal 2023 was $59.00K, a 43.90% increase from fiscal 2022.
  • TVARDI THERAPEUTICS, INC. increase (decrease) in other receivables for fiscal 2022 was $41.00K.
  • TVARDI THERAPEUTICS, INC. increase (decrease) in other receivables for fiscal 2021 was -$102.00K.
Period endIncrease (Decrease) in Other Receivables 3 monthIncrease (Decrease) in Other Receivables 6 monthIncrease (Decrease) in Other Receivables 9 monthIncrease (Decrease) in Other Receivables 12 month
2025-03-31-$579.00K
10-Q · filed 2025-05-13
$76.00K
derived: sum of 2 quarters · filed 2025-05-13
$246.00K
derived: sum of 3 quarters · filed 2025-05-13
$504.00K
derived: sum of 4 quarters · filed 2025-05-13
2024-12-31$655.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-11
$825.00K
derived: sum of 2 quarters · filed 2025-03-11
$1.08M
derived: sum of 3 quarters · filed 2025-03-11
$1.03M
10-K · filed 2025-03-11
2024-09-30$170.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14
$428.00K
derived: sum of 2 quarters · filed 2024-11-14
$379.00K
10-Q · filed 2024-11-14
-$748.00K
derived: sum of 4 quarters · filed 2025-05-13
2024-06-30$258.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-14
$209.00K
10-Q · filed 2024-08-14
-$918.00K
derived: sum of 3 quarters · filed 2025-05-13
$344.00K
derived: sum of 4 quarters · filed 2025-05-13
2024-03-31-$49.00K
10-Q · filed 2025-05-13
-$1.18M
derived: sum of 2 quarters · filed 2025-05-13
$86.00K
derived: sum of 3 quarters · filed 2025-05-13
$11.00K
derived: sum of 4 quarters · filed 2025-05-13
2023-12-31-$1.13M
derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-11
$135.00K
derived: sum of 2 quarters · filed 2025-03-11
$60.00K
derived: sum of 3 quarters · filed 2025-03-11
$59.00K
10-K · filed 2025-03-11
2023-09-30$1.26M
derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14
$1.19M
derived: sum of 2 quarters · filed 2024-11-14
$1.19M
10-Q · filed 2024-11-14
$1.23M
derived: sum of 4 quarters · filed 2025-03-11
2023-06-30-$75.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-14
-$76.00K
10-Q · filed 2024-08-14
-$31.00K
derived: sum of 3 quarters · filed 2025-03-11
-$48.00K
derived: sum of 4 quarters · filed 2025-03-11
2023-03-31-$1.00K
10-Q · filed 2024-05-13
$44.00K
derived: sum of 2 quarters · filed 2025-03-11
$27.00K
derived: sum of 3 quarters · filed 2025-03-11
$57.00K
derived: sum of 4 quarters · filed 2025-03-11
2022-12-31$45.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-11
$28.00K
derived: sum of 2 quarters · filed 2025-03-11
$58.00K
derived: sum of 3 quarters · filed 2025-03-11
$41.00K
10-K · filed 2025-03-11
2022-09-30-$17.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13
$13.00K
derived: sum of 2 quarters · filed 2023-11-13
-$4.00K
10-Q · filed 2023-11-13
-$19.90M
derived: sum of 4 quarters · filed 2024-03-06
2022-06-30$30.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-07
$13.00K
10-Q · filed 2023-08-07
-$19.88M
derived: sum of 3 quarters · filed 2024-03-06
$163.00K
derived: sum of 4 quarters · filed 2024-03-06
2022-03-31-$17.00K
10-Q · filed 2023-05-15
-$19.91M
derived: sum of 2 quarters · filed 2024-03-06
$133.00K
derived: sum of 3 quarters · filed 2024-03-06
-$1.81M
derived: sum of 4 quarters · filed 2024-03-06
2021-12-31-$19.89M
derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-06
$150.00K
derived: sum of 2 quarters · filed 2024-03-06
-$1.79M
derived: sum of 3 quarters · filed 2024-03-06
-$102.00K
10-K · filed 2024-03-06
2021-09-30$20.05M
derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-07
$18.11M
derived: sum of 2 quarters · filed 2022-11-07
$19.79M
10-Q · filed 2022-11-07
$19.89M
derived: sum of 4 quarters · filed 2023-03-06
2021-06-30-$1.94M
derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-08
-$252.00K
10-Q · filed 2022-08-08
-$157.00K
derived: sum of 3 quarters · filed 2023-03-06
-$181.00K
derived: sum of 4 quarters · filed 2023-03-06
2021-03-31$1.69M
10-Q · filed 2022-05-09
$1.78M
derived: sum of 2 quarters · filed 2023-03-06
$1.76M
derived: sum of 3 quarters · filed 2023-03-06
$1.40M
derived: sum of 4 quarters · filed 2023-03-06
2020-12-31$95.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-06
$71.00K
derived: sum of 2 quarters · filed 2023-03-06
-$290.00K
derived: sum of 3 quarters · filed 2023-03-06
-$414.00K
10-K · filed 2023-03-06
2020-09-30-$24.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-08
-$385.00K
derived: sum of 2 quarters · filed 2021-11-08
-$509.00K
10-Q · filed 2021-11-08
-$322.00K
derived: sum of 4 quarters · filed 2022-03-01
2020-06-30-$361.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-09
-$485.00K
10-Q · filed 2021-08-09
-$298.00K
derived: sum of 3 quarters · filed 2022-03-01
-$119.00K
derived: sum of 4 quarters · filed 2022-03-01
2020-03-31-$124.00K
10-Q · filed 2021-05-10
$63.00K
derived: sum of 2 quarters · filed 2022-03-01
$242.00K
derived: sum of 3 quarters · filed 2022-03-01
-$172.00K
derived: sum of 4 quarters · filed 2022-03-01
2019-12-31$187.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01
$366.00K
derived: sum of 2 quarters · filed 2022-03-01
-$48.00K
derived: sum of 3 quarters · filed 2022-03-01
$45.00K
10-K · filed 2022-03-01
2019-09-30$179.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-09
-$235.00K
derived: sum of 2 quarters · filed 2020-11-09
-$142.00K
10-Q · filed 2020-11-09
$591.00K
derived: sum of 4 quarters · filed 2021-02-25
2019-06-30-$414.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-10
-$321.00K
10-Q · filed 2020-08-10
$412.00K
derived: sum of 3 quarters · filed 2021-02-25
$489.00K
derived: sum of 4 quarters · filed 2021-02-25
2019-03-31$93.00K
10-Q · filed 2020-05-11
$826.00K
derived: sum of 2 quarters · filed 2021-02-25
$903.00K
derived: sum of 3 quarters · filed 2021-02-25
$935.00K
derived: sum of 4 quarters · filed 2021-02-25
2018-12-31$733.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25
$810.00K
derived: sum of 2 quarters · filed 2021-02-25
$842.00K
derived: sum of 3 quarters · filed 2021-02-25
$803.00K
10-K · filed 2021-02-25
2018-09-30$77.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-05
$109.00K
derived: sum of 2 quarters · filed 2019-11-05
$70.00K
10-Q · filed 2019-11-05
$96.00K
derived: sum of 4 quarters · filed 2020-02-27
2018-06-30$32.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-07
-$7.00K
10-Q · filed 2019-08-07
$19.00K
derived: sum of 3 quarters · filed 2020-02-27
-$59.00K
derived: sum of 4 quarters · filed 2020-02-27
2018-03-31-$39.00K
10-Q · filed 2019-05-07
-$13.00K
derived: sum of 2 quarters · filed 2020-02-27
-$91.00K
derived: sum of 3 quarters · filed 2020-02-27
-$899.00K
derived: sum of 4 quarters · filed 2020-02-27
2017-12-31$26.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-27
-$52.00K
derived: sum of 2 quarters · filed 2020-02-27
-$860.00K
derived: sum of 3 quarters · filed 2020-02-27
$36.00K
10-K · filed 2020-02-27
2017-09-30-$78.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-06
-$886.00K
derived: sum of 2 quarters · filed 2018-11-06
$10.00K
10-Q · filed 2018-11-06
-$18.00K
derived: sum of 4 quarters · filed 2019-03-12
2017-06-30-$808.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-07
$88.00K
10-Q · filed 2018-08-07
$60.00K
derived: sum of 3 quarters · filed 2019-03-12
-$76.00K
derived: sum of 4 quarters · filed 2019-03-12
2017-03-31$896.00K
10-Q · filed 2018-05-09
$868.00K
derived: sum of 2 quarters · filed 2019-03-12
$732.00K
derived: sum of 3 quarters · filed 2019-03-12
$855.00K
derived: sum of 4 quarters · filed 2019-03-12
2016-12-31-$28.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-12
-$164.00K
derived: sum of 2 quarters · filed 2019-03-12
-$41.00K
derived: sum of 3 quarters · filed 2019-03-12
$7.00K
10-K · filed 2019-03-12
2016-09-30-$136.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-02
-$13.00K
derived: sum of 2 quarters · filed 2017-11-02
$35.00K
10-Q · filed 2017-11-02
-$2.03M
derived: sum of 4 quarters · filed 2018-03-15
2016-06-30$123.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-03
$171.00K
10-Q · filed 2017-08-03
-$1.89M
derived: sum of 3 quarters · filed 2018-03-15
2016-03-31$48.00K
10-Q · filed 2017-05-04
-$2.02M
derived: sum of 2 quarters · filed 2018-03-15
2015-12-31-$2.06M
derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-15
$80.00K
10-K · filed 2018-03-15
2015-09-30$2.14M
10-Q · filed 2016-11-04
2014-06-30$480.00K
10-Q · filed 2015-08-10
2013-06-30$31.00K
10-Q · filed 2014-08-07
2012-12-31-$18.00K
10-K · filed 2015-03-27

Similar stocks

Stock NameCountryMarket CapPE Ratio
Vyome Holdings, Inc (HIND)United States$0.014B-1.38
BullFrog AI Holdings, Inc. (BFRG)United States$0.014B
ACTUATE THERAPEUTICS, INC. (ACTU)United States$0.015B
Anebulo Pharmaceuticals, Inc. (ANEB)United States$0.015B
LISATA THERAPEUTICS, INC. (LSTA)United States$0.014B-2.13
Lantern Pharma Inc. (LTRN)United States$0.015B-2.87
Vistagen Therapeutics, Inc. (VTGN)United States$0.013B-0.14
MUSTANG BIO, INC. (MBIO)United States$0.013B
Citius Pharmaceuticals, Inc. (CTXR)United States$0.016B-133.06
AEON Biopharma, Inc. (AEON)United States$0.013B-0.36